Edie I Crosse

6PUBLICATIONS
43CO-AUTHORS
Haematological tumoursMolecular targetsPredictive and prognostic markersEpigenetics (incl. genome methylation and epigenomics)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jul 09, 2025
An Isoform-Specific RUNX1C-BTG2 Axis Governs AML Quiescence and Chemoresistance.

Cuijuan Han, Zhiping Zhang, Edie I Crosse

|Apr 30, 2025
Muscleblind-like proteins are novel modulators of the tumor-immune microenvironment.

Austin M Gabel, Edie I Crosse, Andrea E Belleville

|Apr 06, 2025
Distinct routes of clonal progression in SF3B1-mutant myelodysplastic syndromes.

Martina Sarchi, Courtnee A Clough, Anna Gallì

|Jun 10, 2024
Mis-splicing of Mitotic Regulators Sensitizes SF3B1-Mutated Human HSCs to CHK1 Inhibition.

Martina Sarchi, Courtnee A Clough, Edie I Crosse

|Feb 01, 2024
Multiplexed screening reveals how cancer-specific alternative polyadenylation shapes tumor growth in vivo.

Austin M Gabel, Andrea E Belleville, James D Thomas

|Oct 16, 2023
An interactive resource of molecular signalling in the developing human haematopoietic stem cell niche.

Edie I Crosse, Anahi Binagui-Casas, Sabrina Gordon-Keylock

Pageof 1